How is Sinusoidal Obstruction Syndrome (SOS) Treated in India?

Sinusoidal obstruction syndrome (SOS) treatment in India requires specialized care, particularly for post-transplant patients. SOS, also known as VOD, can rapidly progress if untreated. Although awareness is improving, access to advanced therapies remains limited. Defitelio® (defibrotide sodium) is globally used for treating SOS with complications after HSCT. Since Defitelio in India is not commercially approved, it is accessed through a regulated import under the Named Patient Program. Indian Pharma Network helps streamline this process by managing documentation, sourcing, and delivery. If you are exploring SOS treatment options in India, connect with experts who can guide you through compliant access pathways. Reach out via WhatsApp +91-9810469557 or call +91-9654860915 for more details.